Intrinsic Value

The intrinsic value of Getinge AB (GTN) under the Base Case is 21.67 EUR per share. Compared with the current market price of 25.25 EUR, the stock appears Overvalued by 14% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

GTN Intrinsic Value
€21.67
Overvaluation 14%
Intrinsic Value
Price €25.25
Alert me when GTN is below its intrinsic value
Today €17.33 · 31.4% below the current price

GTN is more expensive than usual. It was this expensive or more expensive on just 5% of days in the past 5 years.

Alternatives to GTN

Fundamental Analysis

What Getinge AB Does

Health Care

Getinge AB is a Swedish medical technology company that makes equipment and systems used in hospitals, operating rooms, intensive care units, and sterilization departments. Its products include surgical tables and lights, anesthesia and ventilator equipment, heart-lung and extracorporeal circulation systems, infection control and sterilization machines, and other tools used in critical care and surgery.

Headquarters
Sweden SE
Employees
10 729
IPO date
Jun 8, 1995
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Getinge AB

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

GETI B Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one GTN stock?

The intrinsic value for Getinge AB (GTN) under the Base Case is 21.67 EUR.

Is GTN stock undervalued or overvalued?

Compared with the current market price of 25.25 EUR, the stock appears Overvalued by 14% .

Back to Top